Advances in materials and manufacturing processes, developments in sequencing technologies and microfluidics, and breakthroughs in large-scale imaging equipment—from new materials to new technologies—are driving rapid growth in the medical device sector. With the frequent introduction of policies such as centralized procurement, registration management, and unannounced inspections, alongside the expansion of pilot cities for the Medical Device Registrant system, how should these regulatory policies be interpreted? As ongoing policy incentives encourage innovation in medical devices and healthcare institutions at all levels expand and upgrade, how can medical device companies—facing steadily growing demand across various segments—seize these opportunities? Capital support has injected substantial vitality into domestically produced medical device enterprises; how can investors identify the hottest investment trends in this market?
The Golden Decade Has Arrived, and We Are Here at the Right Time.
July 28, 2020, hosted by the People's Government of Gaochun District, organized by the Gaochun District Science and Technology Bureau and VCBeat, and co-organized by Jiangsu Gaochun High-Tech Industrial Development Zone, “The 2nd International Summit on Medical Device Innovation”will beNanjing · GaochunExpand.
This conference will2020 Medical Device Innovation Vitality Listas an opportunity for the release, focusing onThe Future of the Medical Device IndustryDevelopment, In-Depth FocusHot Topics in In Vitro Diagnostics: Digital PCR and Point-of-Care Molecular Diagnostics, bringing together the most dynamic medical device innovators, listed companies, financial institutions, and healthcare organizations from China and abroad to create a premier industry event.

Time:July 28, 2020
Location:Nanjing · Gaochun · World Village Hotel
Scale:< 100 people
(Due to epidemic prevention requirements, attendance at this summit is limited. Please plan your schedule accordingly and register promptly.)
Zhang Yuanting, Academician of the International Academy of Medical and Biological Engineering, and Tian Jie, Director of the Key Laboratory of Molecular Imaging of the Chinese Academy of Sciences, will join forces with NMPA medical device review experts, members of the National Key R&D Program, scholars from renowned universities, executives of multinational corporations, founders of leading innovative medical device companies, forward-looking medical device investors, and senior department directors to discuss the future of medical devices. Stay tuned.

This summit will focus on in the morning,Future Development of Medical DevicesTo engage in discussion, starting fromInnovative Technologies, Review and Approval, and Listed Company StrategiesFocusDevelopment Opportunities for Medical Devices in the Post-Pandemic Era, this afternoon will delve into niche sectors, withTechnological Breakthroughs and Clinical Value of In Vitro Diagnostics: Digital PCR and Point-of-Care Molecular Diagnosticsas the core。
1、On-Site Release of the Four 2020 Medical Device Innovation Vitality Rankings
2. Detailed Interpretation of Gaochun District's Investment Environment and Policies
3. What trends will shape the future development of China’s medical device industry? Which domestic medical device subsectors hold greater growth potential?Leading Academics, Scholars from Renowned Universities, NMPA Medical Device Review Experts, and Microsoft China Join Forces to Interpret Health Engineering, Medical Device Approval, and Investment Trends。

1、Tian Jie, Director of the Key Laboratory of Molecular Imaging, Chinese Academy of SciencesFrom New Medical Materials to Artificial Intelligence
2、RayBiotech, Aoran Biotech, Zytomed Biotech, Hengdao Pathology, Changjiang Biotech, Weigong Technology, Deputy Director of the Department of Laboratory Medicine at Sir Run Run Shaw HospitalShareDigital PCR, Point-of-Care Molecular DiagnosticsTechnological Breakthroughs and Clinical Value of In Vitro Diagnostics。
3. Strategic Director, Guotai JunanDiscussing Investment Hotspots in Medical Devices from the Perspectives of the STAR Market and the Biopharmaceutical Sector of the Hong Kong Stock Exchange.
Time:July 28, 2020
Location:Nanjing · Gaochun · World Village Hotel
Registration:http://e2jwgtki8j1265ap.mikecrm.com/f77Jr87
Scale: Within 100 people
(Due to epidemic prevention requirements, attendance at this offline summit is limited. Please plan your schedule accordingly and register promptly.)

Scan the QR Code to Register
Registration is closing soon. Spaces are limited, so sign up now!
Summit Details:https://vcbeat.top/Forum/summitIndex


Venue: Nanjing Gaochun World Village Hotel (No. 269 Baota Road, Gaochun District, Nanjing)
Distance to Nanjing Lukou International Airport: Approximately 44.68 kilometers
Distance from Nanjing South Railway Station: approximately 71.74 kilometers
Given that Gaochun is located far from Nanjing’s transportation hub, the organizers have specially arranged shuttle buses. The specific arrangements are as follows:

Additionally, if you have ample time, you may visit NanjingSouth Xiangyu RoadTransferS9 Line (Ninggao Line),byXiangyu Road South StationTo Gaochun Metro Station, experience Gaochun, the "International Slow City," up close.
Contracted Hotel: Nanjing Gaochun World Village Hotel
Agreed Rate: CNY 378 per room per night
Hotel Manager: Yang Ling 18551817942

Kind Reminder: Please have your health code ready when checking in at the venue, and scan the QR code at the registration desk to verify your 14-day travel history. Please plan your itinerary reasonably and pay attention to your health.